ProfileGDS4132 / 205781_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 54% 55% 49% 42% 53% 58% 51% 66% 38% 45% 30% 29% 27% 34% 21% 41% 26% 33% 35% 32% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101148.9354
GSM201543Muscle PCOS pioglitazone 121143.64255
GSM201544Muscle PCOS pioglitazone 161133.1449
GSM201545Muscle PCOS pioglitazone 201117.55442
GSM201829Muscle PCOS pioglitazone 231152.31553
GSM201830Muscle PCOS pioglitazon 251167.76258
GSM201831Muscle PCOS pioglitazone 271141.25851
GSM201832Muscle PCOS pioglitazone 31182.62366
GSM201833Muscle PCOS pioglitazone 4191.773338
GSM201834Muscle PCOS pioglitazone 81117.06445
GSM201835Muscle PCOS after pioglitazone 10259.316430
GSM201836Muscle PCOS after pioglitazone 12260.000129
GSM201837Muscle PCOS after pioglitazone 16253.434827
GSM201838Muscle PCOS after pioglitazone 20276.17334
GSM201839Muscle PCOS after pioglitazone 23242.2121
GSM201840Muscle PCOS after pioglitazone 252100.9441
GSM201841Muscle PCOS after pioglitazone 27248.292526
GSM201842Muscle PCOS after pioglitazone 3267.173833
GSM201843Muscle PCOS after pioglitazone 4285.322535
GSM201844Muscle PCOS after pioglitazone 8273.043232